Patents by Inventor Alexander Arrow

Alexander Arrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290223
    Abstract: There is provided a suture passer device used in procedures of robotic assisted minimally invasive suspension of the hyoid and tongue base in treatment of sleep apnea. The suture passer device is a dual use suture passer, having both suture insertor and extractor functionality on a single unitary instrument section of the device by means of insertion and extraction hooks positioned on an elongated needlelike body which is connected to a handle grip. The insertion and extraction hooks receive a suture via an opening in the body of the instrument, with the suture capable of removal and fastening to the extraction hook by robotic forceps. Procedures for using the device are disclosed which include a single point of entry on a patient and the device moved to first and second positions above and below the hyoid bone during robotic assisted surgery.
    Type: Application
    Filed: January 20, 2021
    Publication date: September 23, 2021
    Inventors: Yosef Krespi, Ron Hadani, Alexander Arrow, Richard Lilly
  • Patent number: 10105550
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: October 23, 2018
    Assignee: Circuit Therapeutics, Inc.
    Inventors: Greg Stahler, Ananya Mitra, Joyce Huang, Dan Andersen, Alexander Arrow, David Moore
  • Publication number: 20160096034
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 28, 2014
    Publication date: April 7, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander Arrow
  • Publication number: 20160096035
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 28, 2014
    Publication date: April 7, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander Arrow
  • Publication number: 20160051836
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 28, 2014
    Publication date: February 25, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander Arrow
  • Publication number: 20160051838
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 25, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Greg Stahler, Ananya Mitra, Joyce Huang, Dan Andersen, Alexander Arrow, David Moore
  • Publication number: 20160051831
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 25, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Fred Moll, Alexander Arrow
  • Publication number: 20160045765
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 18, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Fred Moll, Alexander Arrow
  • Publication number: 20160038758
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 31, 2014
    Publication date: February 11, 2016
    Applicant: CIRCUIT THERAPEUTICS, INC.
    Inventors: Greg Stahler, Ananya Mitra, Joyce Huang, Dan Andersen, Alexander Arrow, David Moore
  • Publication number: 20160038755
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: July 28, 2014
    Publication date: February 11, 2016
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander Arrow
  • Publication number: 20130082016
    Abstract: One embodiment is directed to a system for improving triathlon transition area efficiency, comprising a main stand member comprising a base portion and a top portion, the base portion being configured to be supported by a ground surface; and a first shoe coupler fixedly coupled to the top portion of the main stand member and configured to removably couple a first shoe to the main stand member in a manner wherein a pose is established for the first shoe such that a foot of a standing athlete may be urged into the first shoe without the use of one or more hands of the athlete to stabilize the shoe.
    Type: Application
    Filed: August 31, 2012
    Publication date: April 4, 2013
    Applicant: Triathalon Scientific, Inc.
    Inventor: Alexander Arrow
  • Publication number: 20130056954
    Abstract: Embodiments are described for assisting an athlete in obtaining consumables such as food and sunblock while racing on a bicycle without slowing down, endangering him/herself, or performing unhygienic acts. In one embodiment, a mechanical one-hand-operable food-dispensing container may be coupled to a cyclist's bicycle such that it may be easily reached, and the solid pieces of food dispensed easily palmed by the same hand that operates it while the cyclist is racing. In another embodiment, a one-hand-operable liquid-sunblock-dispensing pump may be coupled to a cyclist's aerobars, such that its plunger may be depressed by the cyclist's thumb and the palm of the same hand may be positioned to receive the expelled sunblock, enabling the racer to apply sunblock without slowing down or endangering him/herself.
    Type: Application
    Filed: June 29, 2012
    Publication date: March 7, 2013
    Inventor: Alexander Arrow
  • Publication number: 20130047683
    Abstract: Embodiments are described for assisting an athlete in securely storing personal items such as keys, a smartphone, a camera, and the like in an outdoor triathlon transition area while he/she competes in the race. The locker is configured to lock the personal items securely with a combination or key, and in one embodiment, the locker may be additionally lockable to a triathlon transition area horizontal bicycle racking bar, and may be poseable from a position/orientation perspective relative to the racking bar. In one embodiment, the locker may be configured to have a watertight enclosure.
    Type: Application
    Filed: August 9, 2012
    Publication date: February 28, 2013
    Inventor: Alexander Arrow
  • Publication number: 20120314832
    Abstract: Embodiments are described for assisting an athlete in counting laps on a repetitive course, and providing feedback to the athlete during the event regarding the number of laps that have been completed. In one embodiment, a mechanical or digital counter may be coupled to a runner, cyclist, cyclist's bicycle, or swimmer such that an input interface may be easily reached, and such that a feedback interface may be viewed during the event. In other embodiments, an input interface may be automated with wireless technologies, and the athlete may be provided with counting and/or timing feedback through a feedback interface coupled to the athlete that may be viewed during the event.
    Type: Application
    Filed: October 3, 2011
    Publication date: December 13, 2012
    Inventor: Alexander Arrow